Oxygen Therapy Prevents Ventricular Arrhythmias in Patients With Congestive Heart Failure and Sleep Apnea
-
- Suzuki Jun-ichi
- Departments of Cardiovascular Medicine, Tokyo Medical and Dental University Graduate School of Medicine and Dentistry
-
- Ishihara Takashi
- Departments of Cardiovascular Medicine, Tokyo Medical and Dental University Graduate School of Medicine and Dentistry
-
- Sakurai Kaoru
- Departments of Cardiovascular Medicine, Tokyo Medical and Dental University Graduate School of Medicine and Dentistry
-
- Inagaki Hiroshi
- Departments of Cardiovascular Medicine, Tokyo Medical and Dental University Graduate School of Medicine and Dentistry
-
- Kawabata Mihoko
- Departments of Cardiovascular Medicine, Tokyo Medical and Dental University Graduate School of Medicine and Dentistry
-
- Hachiya Hitoshi
- Departments of Cardiovascular Medicine, Tokyo Medical and Dental University Graduate School of Medicine and Dentistry
-
- Hata Akihiro
- Departments of Cardiovascular Medicine, Tokyo Medical and Dental University Graduate School of Medicine and Dentistry
-
- Hirao Kenzo
- Departments of Cardiovascular Medicine, Tokyo Medical and Dental University Graduate School of Medicine and Dentistry
-
- Hasegawa Makoto
- Sleep-Related Respiratory Disorders, Tokyo Medical and Dental University Graduate School of Medicine and Dentistry
-
- Isobe Mitsuaki
- Departments of Cardiovascular Medicine, Tokyo Medical and Dental University Graduate School of Medicine and Dentistry
Search this article
Abstract
Background Although ventricular arrhythmia is critical for the prognosis of patients with severe congestive heart failure (CHF), it is difficult to control the arrhythmia using conservative therapies. However, many CHF patients also have sleep apnea syndrome (SAS) and oxygen supply improves their prognosis. The beneficial effects of oxygen treatment for ventricular arrhythmia have not yet been clarified, so the present study was designed to evaluate the effects of oxygen treatment for premature ventricular contraction (PVC). Methods and Results Patients with CHF and SAS were divided into 3 groups: (1) the "PVC declined" group that included patients who had frequent PVCs and oxygen treatment that suppressed the number of PVC; (2) the "PVC not affected" group that included patients who had frequent PVCs and oxygen treatment did not affect the number of PVC; and (3) the "few PVC" group that included patients who had no or few PVCs. The group 1 patients showed higher apnea-hypopnea index, standard deviation of all R-R intervals, left ventricular ejection fraction, and brain natriuretic peptide levels than the patients in group 2. Oxygen treatment in group 3 did not affect the PVC frequency. Conclusions Oxygen treatment may be useful for preventing ventricular arrhythmia in selected patients with CHF and SAS. (Circ J 2006; 70: 1142 - 1147)<br>
Journal
-
- Circulation Journal
-
Circulation Journal 70 (9), 1142-1147, 2006
The Japanese Circulation Society
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001205102692480
-
- NII Article ID
- 110004814888
-
- NII Book ID
- AA11591968
-
- ISSN
- 13474820
- 13469843
- http://id.crossref.org/issn/13469843
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed